European Archives - Page 294 of 1125 - European Medical Journal

Atypical Lemierre’s Syndrome

A previously healthy 17-year-old male was transferred from a community hospital to the authors’ tertiary paediatric emergency department…

Dermatitis Artefacta Treatment

Dermatitis artefacta (DA), also known as artefactual skin disease, is a rare psychocutaneous disorder characterised by…

Nipah Outbreak in Kerala: Local Dynamics and Global Threats

Nipah virus disease is a zoonotic infection caused by the Nipah virus (NiV) of the Genus Henipavirus of the Paramyxoviridae family…

Penile Skin Bridge Causing Painful Spontaneous Erection

Erection is a neurovascular response accompanied by the release of neurotransmitters. The penis is innervated by autonomic (sympathetic…

Central Line Bloodstream Infection

Infection leads to an increased rate and duration of hospitalisation, increased treatment costs, and high morbidity and mortality in…

Caregiver Burden, Resilience, and Wellbeing in Cases of SCAR

Severe cutaneous adverse drug reactions (SCAR) are a group of rare but potentially life-threatening conditions that can occur in response…

Endovascular Stenting for Superior Vena Cava Syndrome

Superior vena cava syndrome (SVCS) is a group of clinical manifestations, caused by an obstruction of venous blood flow to the heart…

Prediagnostic Proteomics of Gout: Abstracts from EULAR 2024

A study presented at EULAR 2024 aimed to investigate the relationship between large-scale pre-diagnostic proteomics and the risk of incident gout in a nationwide prospective cohort.

Anti-Ro/SSA Antibodies in Systemic Sclerosis Stratification: Abstracts from EULAR 2024

Research presented at EULAR 2024 aimed to evaluate the prevalence of anti-Ro/SSA antibodies in the largest available cohort of established systemic sclerosis patients.

VML Health's Nichole Davies on the good, the bad and the ugly in women’s health

VML’s Chief Strategy Officer, Nichole Davies, talks about the pharma industry’s role in improving the quality of women’s health worldwide, including why investors need to wake up to women’s health issues.